智通财经APP讯，密尔克卫(603713.SH)发布公告，公司实际控制人、控股股东陈银河先生计划通过大 宗交易、集中竞价交易方式减持公司股份数量不超过237.18万股，即减持不超过公司总股本的1.50%， 自公告之日起15个交易日后的3个月内进行。 公司实际控制人、股东李仁莉女士计划通过大宗交易、集中竞价交易方式减持公司股份数量不超过 237.18万股，即减持不超过公司总股本的1.50%，自公告之日起15个交易日后的3个月内进行。 公司股东君联茂林计划通过大宗交易、集中竞价交易方式减持公司股份数量不超过161.66万股，即减持 不超过公司总股本的1.02%，自公告之日起3个交易日后的3个月内进行。 ...

密尔克卫公告，公司控股股东陈银河计划在未来三个月内，通过大宗交易和集中竞价方式减持不超过 237.18万股，占总股本的1.5%。同时，股东李仁莉也计划减持不超过相同数量的股份。公司股东君联茂 林则计划减持不超过161.66万股，占总股本的1.02%。减持原因均为自身资金需求。减持计划将于公告 之日起15个交易日后的三个月内进行。 ...

Market Overview - On September 25, the logistics sector declined by 0.71% compared to the previous trading day, with Huapengfei leading the decline [1] - The Shanghai Composite Index closed at 3853.3, down 0.01%, while the Shenzhen Component Index closed at 13445.9, up 0.67% [1] Individual Stock Performance - China National Foreign Trade (601598) saw a closing price of 7.80, with a significant increase of 7.44% and a trading volume of 692,900 shares, amounting to 524 million yuan [1] - Huapengfei (300350) closed at 6.76, down 5.59%, with a trading volume of 702,900 shares and a turnover of 479 million yuan [2] - Other notable stocks include Zhejiang Merchants Zhongtuo (000906) with a slight increase of 0.66% and a closing price of 6.06, and ST Guangwu (600603) which decreased by 0.35% to 8.65 [1][2] Capital Flow Analysis - The logistics sector experienced a net outflow of 434 million yuan from institutional investors, while retail investors saw a net inflow of 297 million yuan [2] - Major stocks like China National Foreign Trade had a net inflow of 43.04 million yuan from institutional investors, but a net outflow from retail investors of 33.37 million yuan [3] - Other stocks such as Jiayou International (603871) and Milkewei (603713) also showed mixed capital flows, with Jiayou International experiencing a net inflow of 9.51 million yuan from institutional investors [3]

Core Viewpoint - The company, Milkwell, announced that it has no overdue guarantees, indicating a stable financial position and management of liabilities [2] Group 1 - The announcement was made on the evening of September 19 [2] - The company reassured stakeholders regarding its financial health by confirming the absence of overdue guarantees [2]

Company Overview - Milkyway's external guarantee balance amounts to approximately RMB 5.135 billion, which represents 118.93% of the company's most recent audited net assets attributable to shareholders [1] - As of the report date, Milkyway's market capitalization stands at RMB 10.4 billion [1] Revenue Composition - For the first half of 2025, Milkyway's revenue composition is as follows: logistics accounts for 51.39%, trading for 48.08%, and other businesses for 0.53% [1]

累计担保情况 | 证券代码：603713 | 证券简称：密尔克卫 | 公告编号：2025-083 | | --- | --- | --- | | 转债代码：113658 | 转债简称：密卫转债 | | 密尔克卫智能供应链服务集团股份有限公司 关于为控股子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | | 被担保人名称 | 上海化运新辉供应链管理有限公司（以 下简称"化运新辉"） | | | | --- | --- | --- | --- | --- | | 担保对象一 | 本次担保金额 | 1,100.00 | 万元 | | | | 实际为其提供的担保余额 | 1,100.00 | 万元 | | | | 是否在前期预计额度内 | 是 | □否 | □不适用：_________ | | | 本次担保是否有反担保 | □是 | 否 | □不适用：_________ | | | 被担保人名称 | 简称"山海精舍"） | | 上海山海精舍科技商贸有限公司（以下 | | 担 ...

Group 1 - The core logic behind the focus on the chemical industry is influenced by three main factors: environmental regulations, high energy costs due to the Russia-Ukraine war, and weak demand, leading to production cuts by major chemical companies in Europe [3] - Europe has closed approximately 11 million tons per year of chemical production capacity over the past two years, with the capacity utilization rate in the EU27 dropping to 74% in the first quarter [3] - Germany's chemical capacity utilization rate fell to 72% in the second quarter, marking the lowest level in nearly 30 years [3] Group 2 - The company "Milky Way" (密尔克卫, 603713.SH), often referred to as the "Amazon of Chemicals," is a significant topic in the chemical industry, especially following the recent half-year report [4]

Core Viewpoint - The report from Tianfeng Securities indicates that Milkyway's main business prices are either at historical lows or experiencing minimal year-on-year fluctuations, which negatively impacts profit growth [1] Price Trends and Profitability - Shipping rates in global freight have seen significant declines, while prices for chemicals and domestic chemical shipping rates remain low [1] - Future price recovery is anticipated due to economic recovery, stabilization in the chemical industry, and reduced competition, which could accelerate profit growth for Milkyway [1] - Even with a price decline in the first half of 2025, Milkyway's net profit attributable to shareholders is expected to grow by 13%, demonstrating strong growth resilience [1] Potential for Profit Growth - If the year-on-year price decline narrows or turns into an increase, Milkyway's net profit could see accelerated growth, leading to a potential rise in valuation [1] - Price increases could also reduce business risks and lower asset and credit impairment losses, further driving up valuation [1] Market Sentiment and Valuation - As market risk appetite increases, the risk premium for trade businesses is expected to narrow, which may lead to a rise in Milkyway's valuation [1] - The expectation of price stabilization and continued growth in business volume could gradually release profits [1] - A target price-to-earnings ratio of 16 times is set, corresponding to a target price of 81.49 yuan, with an initial "buy" rating assigned [1]

Group 1: Macro Strategy and Market Overview - The report emphasizes the importance of coordinated fiscal and monetary policies to support economic recovery amid a complex market environment [3] - In the equity market, major indices experienced slight adjustments, with the ChiNext Index rising by 2.35% in the first week of September [3] - The central bank maintained a loose liquidity environment, with the DR007 rate staying below 1.5% [3] Group 2: Pharmaceutical Industry Insights - The weight loss market is rapidly growing, with over 2.6 billion people affected by overweight/obesity globally as of 2020, projected to exceed 4 billion by 2035 [5] - Novo Nordisk's oral version of semaglutide has been accepted for FDA review, marking a significant advancement in the oral GLP-1 weight loss drug market [5] - Data underperformance in oral GLP-1 pipelines may accelerate domestic BD opportunities, with potential for local drug companies to achieve significant results [5] Group 3: Energy Sector Analysis - U.S. shale oil companies have reduced capital expenditure and production guidance for 2025, indicating a cautious outlook [6][8] - The report predicts that if WTI prices remain below $60 per barrel, shale oil production may decline significantly [8] - OPEC+ is expected to increase production, potentially leading to oversupply and price corrections in the fourth quarter [9] Group 4: Chemical Industry Developments - China has become the world's largest new energy storage market, with installed capacity reaching 73.76 million kilowatts by the end of 2024 [11] - Prices for paraquat have risen due to strong demand and tight supply, while epoxy chloropropane market transactions have increased [11] Group 5: Retail Sector Performance - Chongqing Department Store reported a revenue of 8 billion yuan in H1 2025, a 10% year-on-year decline, but net profit increased by 8.7% [12] - The company has successfully adjusted 32 stores, resulting in a 53% increase in customer traffic [12] Group 6: Company-Specific Insights - Milky Way's net profit is expected to grow from 6.6 billion to 9.3 billion yuan from 2025 to 2027, with a target price of 81.49 yuan based on a PE of 16 [42][43] - China Ruyi's revenue for H1 2025 reached 2.206 billion yuan, a 19.93% increase, with a net profit turnaround to 1.228 billion yuan [36][37]

Investment Rating - The report assigns a "Buy" rating for the company, with a target price of 81.49 CNY based on a target PE of 16 times [6]. Core Insights - The company's main business prices are at historical lows, which has negatively impacted profit growth. However, prices are expected to recover with economic recovery and stabilization in the chemical industry, potentially accelerating profit growth [1][49]. - The company is actively expanding its business volume through product diversification, regional expansion, and market share increase, leading to sustained growth in freight forwarding, chemical sales, shipping, and warehousing [2]. - Profitability is expected to increase, and valuation may rise as profit growth accelerates and risk preferences improve among investors [3]. Summary by Sections 1. Company Overview - The company is a leading provider of integrated supply chain services in China, focusing on freight forwarding, warehousing, and transportation, with a strong emphasis on chemical distribution [15][29]. 2. Price Recovery Potential - Current prices related to the company's main business are at historical lows, affecting profit growth. Future price recovery is anticipated due to economic recovery and stabilization in the chemical sector [1][49]. 3. Business Growth Strategies - The company is expanding its product categories, regions, and market share, with significant growth expected in freight forwarding and chemical distribution [2][41]. 4. Profitability and Valuation - The company is projected to achieve net profits of 660.95 million CNY, 805.34 million CNY, and 932.98 million CNY for the years 2025, 2026, and 2027 respectively, indicating strong profit growth [4][5]. - The company's valuation is expected to rise as profit growth accelerates and market risk preferences improve [3][44]. 5. Financial Data - The company’s revenue is projected to grow from 9,752.55 million CNY in 2023 to 16,738.82 million CNY in 2027, with a CAGR of 39% from 2015 to 2024 [5][44].